Last reviewed · How we verify

NCT04192201

A Real-world Study for Patients With Multiple Pulmonary Ground-glass Nodules

Status unknown Last updated 10 December 2019
What this trial tests

trial in Multiple Pulmonary Nodules in 200 participants. Status unknown.

Timeline
31 December 2019
Primary endpoint
31 December 2021
31 December 2024

Quick facts

Lead sponsorTongji Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date31 December 2019
Primary completion31 December 2021
Estimated completion31 December 2024
Sites1 location across China

Conditions studied

Sponsor

Tongji Hospital

Who can join

18 and older, any sex, with Multiple Pulmonary Nodules. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to actively monitor patients with multiple pulmonary Ground-glass Nodules (GGNs), in order to provide evidence for multiple GGNs treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Pulmonary Nodules

Currently open trials in the same condition.

Other Tongji Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04192201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing